Osamu Ohno Selected Research

Osamu Ohno Research Topics

9	Neoplasms (Cancer) 06/2019 - 11/2007
3	Obesity 12/2016 - 08/2015
2	Carcinoma (Carcinomatosis) 02/2021 - 03/2013
2	Leukemia 10/2015 - 03/2013
2	Melanoma (Melanoma, Malignant) 01/2011 - 01/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2019
1	Pulmonary Embolism 06/2018
1	Thrombosis (Thrombus) 06/2018
1	Cardiac Papillary Fibroelastoma 04/2017
1	Thromboembolism 04/2017
1	Neuroblastoma 12/2009
1	Hypertension (High Blood Pressure) 08/2008
1	Inflammation (Inflammations) 06/2008
1	Atherosclerosis 01/2005
1	Neoplasm Metastasis (Metastasis) 01/2005

2	DNA (Deoxyribonucleic Acid)IBA 06/2019 - 11/2007
2	yoshinone AIBA 12/2016 - 01/2016
2	MacrolidesIBA 06/2014 - 03/2013
2	aplyronine AIBA 03/2013 - 08/2012
2	Melanins (Melanin)IBA 01/2011 - 01/2010
1	ThapsigarginIBA 02/2021
1	paeoniflorigenoneIBA 06/2019
1	moutan cortexIBA 06/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2019
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 06/2019
1	tert-ButylhydroperoxideIBA 06/2019
1	DNA-Activated Protein KinaseIBA 06/2019
1	GalactosidasesIBA 06/2019
1	RivaroxabanIBA 06/2018
1	AnticoagulantsIBA 06/2018
1	KynurenineIBA 01/2018
1	AcetyleneIBA 11/2015
1	LipopeptidesIBA 11/2015
1	halichonine BIBA 10/2015
1	Complex MixturesIBA 08/2015
1	jahanyneIBA 02/2015
1	Biological ProductsIBA 06/2014
1	biselyngbyolide AIBA 06/2014
1	ElementsIBA 03/2013
1	gummiferolIBA 03/2013
1	mycalolide BIBA 03/2013
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2011
1	bakuchiolIBA 01/2010
1	isobavachalconeIBA 01/2010
1	alpha-MSHIBA 01/2010
1	bavachinIBA 01/2010
1	VenomsIBA 12/2009
1	Peptides (Polypeptides)IBA 12/2009
1	benzyl cinnamateIBA 08/2008
1	benzyl benzoate (Ansar)FDA Link 08/2008
1	Angiotensin IIIBA 08/2008
1	complanineIBA 06/2008
1	sangivamycinIBA 11/2007
1	Indicators and Reagents (Reagents)IBA 11/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2007
1	Protein Kinase CIBA 11/2007
1	RNA (Ribonucleic Acid)IBA 11/2007
1	Adenosine Triphosphate (ATP)IBA 11/2007
1	amsonic acid (DAS)IBA 11/2007
1	NF-kappa B (NF-kB)IBA 01/2005

2	Therapeutics 06/2018 - 04/2017